BioMarin Pharmaceutical Inc.BioMarin Pharmaceutical Inc.BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

No trades
See on Supercharts
Market capitalization
‪17.17 B‬USD
‪167.65 M‬USD
‪2.42 B‬USD
‪185.93 M‬
Beta (1Y)
0.32

About BioMarin Pharmaceutical Inc.

CEO
Alexander Hardy
Headquarters
San Rafael
Employees (FY)
‪3.4 K‬
Founded
1997
ISIN
US09061G1013
FIGI
BBG000CZWZ05
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where BMRN is featured.

Frequently Asked Questions

The current price of BMRN is 90.47 USD — it has decreased by 0.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioMarin Pharmaceutical Inc. stocks are traded under the ticker BMRN.
BioMarin Pharmaceutical Inc. is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
BMRN stock is 1.67% volatile and has beta coefficient of 0.32. Check out the list of the most volatile stocks — is BioMarin Pharmaceutical Inc. there?
One year price forecast for BioMarin Pharmaceutical Inc. has a max estimate of 140.00 USD and a min estimate of 80.00 USD.
BMRN earnings for the last quarter are 0.21 USD whereas the estimation was 0.22 USD which accounts for −5.20% surprise. Estimated earnings for the next quarter are 0.20 USD. See more details about BioMarin Pharmaceutical Inc. earnings.
BioMarin Pharmaceutical Inc. revenue for the last quarter amounts to ‪581.33 M‬ USD despite the estimated figure of ‪603.84 M‬ USD. In the next quarter revenue is expected to reach ‪638.82 M‬ USD.
Yes, you can track BioMarin Pharmaceutical Inc. financials in yearly and quarterly reports right on TradingView.
BMRN stock has risen by 2.36% compared to the previous week, the month change is a 7.54% rise, over the last year BioMarin Pharmaceutical Inc. has showed a 9.76% decrease.
BMRN net income for the last quarter is ‪20.38 M‬ USD, while the quarter before that showed ‪40.38 M‬ USD of net income which accounts for −49.54% change. Track more BioMarin Pharmaceutical Inc. financial stats to get the full picture.
Today BioMarin Pharmaceutical Inc. has the market capitalization of ‪17.17 B‬, it has increased by 0.55% over the last week.
No, BMRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BMRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioMarin Pharmaceutical Inc. stock right from TradingView charts — choose your broker and connect to your account.
BMRN reached its all-time high on Jul 20, 2015 with the price of 151.75 USD, and its all-time low was 3.57 USD and was reached on Sep 4, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BioMarin Pharmaceutical Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioMarin Pharmaceutical Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioMarin Pharmaceutical Inc. stock shows the buy signal. See more of BioMarin Pharmaceutical Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BioMarin Pharmaceutical Inc. future price: according to them, BMRN price has a max estimate of 140.00 USD and a min estimate of 80.00 USD. Read a more detailed BioMarin Pharmaceutical Inc. forecast: see what analysts think of BioMarin Pharmaceutical Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioMarin Pharmaceutical Inc. EBITDA is ‪298.12 M‬ USD, and current EBITDA margin is 12.35%. See more stats in BioMarin Pharmaceutical Inc. financial statements.